| Dr Corey D Finch Sr, MD | |
|
507 Ne 12th St, Moore, OK 73160-5807 | |
| (405) 237-9955 | |
| Not Available |
| Full Name | Dr Corey D Finch Sr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 19 Years |
| Location | 507 Ne 12th St, Moore, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407903644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 25495 (Oklahoma) | Secondary |
| 207Q00000X | Family Medicine | 25495 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sooner Health Services, Inc | Norman, OK | Home health agency |
| Lifespring Home Health | Norman, OK | Home health agency |
| Sooner Health Services Iii, Inc | Holdenville, OK | Home health agency |
| Universal Healthcare | Oklahoma city, OK | Home health agency |
| Lifespring Edmond Home Health | Edmond, OK | Home health agency |
| Good Shepherd Hospice, Inc | Oklahoma city, OK | Hospice |
| Humanity Hospice, Llc | Oklahoma city, OK | Hospice |
| Tendercare Hospice | Norman, OK | Hospice |
| Lifespring Hospice | Norman, OK | Hospice |
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Bellevue Health & Rehabilitation Center | Oklahoma city, OK | Nursing home |
| River Oaks Skilled Nursing And Therapy | El reno, OK | Nursing home |
| Stillwater Creek Skilled Nursing And Therapy | Stillwater, OK | Nursing home |
| The Regency Skilled Nursing And Therapy | Shawnee, OK | Nursing home |
| Kingwood Skilled Nursing And Therapy | Oklahoma city, OK | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Long Term Care Specialists, Inc | 3476550740 | 32 |
| Moore Care Llc | 3870870843 | 4 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Purcell Municipal Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467476911 PECOS PAC ID: 7719899400 Enrollment ID: O20031106000100 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Newman Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083617807 PECOS PAC ID: 2567482367 Enrollment ID: O20051122000749 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Long Term Care Specialists, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497761159 PECOS PAC ID: 3476550740 Enrollment ID: O20061030000218 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Hospital Care Consultants Region Ii Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558491449 PECOS PAC ID: 8820197064 Enrollment ID: O20070727000300 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Medical Resource Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104056365 PECOS PAC ID: 4082753918 Enrollment ID: O20100830000840 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Oklahoma Emergency Physician Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891039764 PECOS PAC ID: 0345493649 Enrollment ID: O20130118000115 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Emergency Physicians Of Mid-america Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063825297 PECOS PAC ID: 2062638661 Enrollment ID: O20140716001692 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Newman Memorial Hospital, Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1083617807 PECOS PAC ID: 2567482367 Enrollment ID: O20160811000217 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Entity Name | Moore Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104379148 PECOS PAC ID: 3870870843 Enrollment ID: O20170428000648 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Corey D Finch Sr, MD 8900 Silver Hill Dr, Oklahoma City, OK 73132-3316 Ph: (405) 557-1200 | Dr Corey D Finch Sr, MD 507 Ne 12th St, Moore, OK 73160-5807 Ph: (405) 237-9955 |
News Archive
The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart disease is to use a coronary artery calcium (CAC) test in addition to the most commonly used assessment tool, according to researchers at Wake Forest Baptist Medical Center.
Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.
› Verified 6 days ago
Nazanin Sara Hesami, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 320 N Service Rd, Moore, OK 73160 Phone: 405-794-4474 | |
Dr. Israel Becerra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 S Telephone Rd Ste 250, Moore, OK 73160 Phone: 405-237-7500 | |
Dr. Shelly Dawn Faubion, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 Se 4th St, Moore, OK 73160 Phone: 405-794-4664 Fax: 405-794-2853 | |
Nusrat Rumana, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 S Telephone Rd, Moore, OK 73160 Phone: 405-793-1188 | |
Dr. Sarah Elizabeth Cox, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1060 Sw 4th St, Moore, OK 73160 Phone: 405-378-5491 Fax: 405-378-5492 | |
Chandlar Maria Vazquez, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1060 Sw 4th St, Moore, OK 73160 Phone: 405-378-5491 Fax: 405-378-5492 | |
Kyle Fanning, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 Sw 34th St Ste 200, Moore, OK 73160 Phone: 405-793-1188 Fax: 405-793-0492 |